Chandos Fund
Fishawack Communications
| Website | www.fishawack.com |
|---|---|
| Medical | Healthcare Communications |
| MBO | £6 million |
| Status | Current portfolio investment |
| Date | January 2008 |
| Location | Knutsford and Abingdon |
Fishawack is an established, specialist healthcare communications agency focusing on the medical sector, with a strong reputation for providing specialist support for many of the world's top global pharmaceutical companies including, Sanofi-Aventis, Roche, GSK Bayer-Schering and Shire.
Chandos has introduced Andrew Smith as chairman of the MBO. He has extensive knowledge of both the medical communications sector and the pharmaceutical sector having previously been with Parexel International (USA) and SmithKline Beecham Pharmaceutical.
Mike White, Investment Manager for the Chandos Fund commented "We are pleased to have made our fifth investment from the Chandos Fund within a year of our first close. This is an excellent opportunity to buy into a quality business with a strong reputation for excellent service and knowledge in a growing niche of the market. The Chandos fund has now invested £8.5 million in 5 businesses across the UK and this deal demonstrates our desire to back management teams and entrepreneurs from a variety of industry sectors"
Tim Mustill, MD of Fishawack said "This is a very exciting development for us. Fishawack is a very strong brand with a solid and growing reputation for excellence. We are now very well placed to deliver on our ambitious growth and development plans. YFM Group have been supportive and straightforward throughout the buyout process and are an ideal partner for us as we look to grow"
